When our Publisher was doing CE programs to medical professionals, I remember he used to ask the question, “If there was a drug you could take once a day with no side effects that lowered your A1c, weight and blood pressure, how much would you be willing to pay?” Once …
HELLO KITTY 4-Layer Pink Tutu/Skirt!From the Editor
March, 2022
Latest Articles
May, 2022
-
4 May
SMARTPHONE COACHING AND IMPACT ON GESTATIONAL DIABETES
According to research presented by Dr. Tong Yew at the National University Hospital in Singapore, smartphone coaching in conjunction with usual care resulted in better maternal glycemic control. Gestation diabetes mellitus (GDM) affects around 25% of all pregnancies in Singapore. Cesarean section, preeclampsia, preterm labor, macrosomia, and infant hypoglycemia can …
Read More » -
4 May
SGLT2 Inhibitors and Gout Prevention
Will this standard type 2 diabetes treatment change the treatment choice for patients with gout? Sodium-glucose transport protein 2 (SGLT-2) inhibitors are a staple in treating patients with type 2 diabetes. These drugs were designed for use in patients with type 2 diabetes. It reduces blood glucose levels by helping …
Read More » -
4 May
Effective Weight Management in Diabetes
Effective diets to help manage and maintain healthy lifestyles in diabetic patients Upon receiving a diabetes diagnosis, patients go through many thoughts, one of the first being medication therapy. Besides medication therapy, the critical component for a healthy life with diabetes is maintaining a healthy lifestyle. The beneficial lifestyle modifications …
Read More »
April, 2022
-
25 April
Youth Onset Type 2 Diabetes
According to the research presented by Dr. Petter Bjornstad from the University of Colorado Anschutz Medical Campus, the risk of microvascular complications increases by the time of young adulthood in patients who have diabetes in youth. The onset of type 2 diabetes has increased consistently with the rise of children …
Read More » -
25 April
The role of eating behavior in reducing the risk of type 2 diabetes among nighttime shift workers
Does daytime eating prevent glucose intolerance and internal circadian misalignment in night shift workers? Several studies have suggested that rotating night shift work ((defined as working at least three nights/month in addition to 19 days and evenings in that month) is associated with an increased risk of obesity and metabolic …
Read More »
More Articles
April, 2022
-
25 April
The Application of Exercise Training For Diabetic Peripheral Neuropathy
A number of experimental studies have utilized exercise training to treat various impairments associated with diabetic peripheral neuropathy, such as nerve conduction velocity, pain tolerance, and balance. Chronic diabetes can cause neurological, vascular, and lymphatic disorders, including radiculopathy, plexopathy, and mononeuropathy. However, the most common complication of diabetes is the …
Read More » -
21 April
Patients with diabetes and HF on Metformin and Sulfonylurea show improved clinical outcomes
In patients with type 2 diabetes mellitus, composite mortality/HHF was significantly lower in patients taking metformin versus those taking sulfonylurea. The rising global burden of diabetes and its complications in recent years has called for new Prevention and control programs and alternative treatment approaches for existing treatments based on evidence-based …
Read More » -
21 April
Occupational Consequences in Type 1 Diabetes
According to research presented by Dr. Andrea Dehn-Hindenberg from the Hannover Medical School in Germany, mothers in children with diabetes experience many challenges in their occupational settings. Diabetes is a persistent condition that requires regular maintenance to limit adverse consequences. When a child is diagnosed with diabetes, self-management of the …
Read More » -
21 April
Glucose Management Indicator in Diabetes
According to research presented by Dr. Elena Toschi from Harvard Medical School, a more significant difference between Hba1c and GMI was associated with a higher risk of low blood glucose. A disparity between HbA1c and mean glucose estimated by self-blood glucose observing and continuous glucose monitoring (CGM) has been depicted …
Read More » -
14 April
Diabetes and Liver Ailment in People with Obesity who have a Family History of Type 2 Diabetes
A study on type 2 diabetes and fatty liver disease in diabetes-free people suffering from obesity. Thorough nonalcoholic fatty liver illness, commonly referred to as NAFLD screening, can aid in the early diagnosis and treatment of fatty liver illness. A family’s past of NAFLD, particularly diabetes, has received considerable …
Read More » -
13 April
Irregular Menses: A Signal for Cardiovascular Disease and Diabetes
Compared with women with regular menstrual cycles, women with irregular menses are 20% more likely to develop cardiovascular disease and 17% more likely to develop type 2 diabetes over 20 years. There is a lack of consideration of the link between menstrual disorders and metabolic conditions. Researchers, led by Sylvia …
Read More » -
13 April
Racial Inequity in Diabetes Technology Use Among Medicare Beneficiaries
From 2017 to 2019, White Medicare beneficiaries were more likely to use a continuous glucose monitor or insulin pump than Black beneficiaries. Overall, the use of diabetes technology has increased; however, the gap has increased over the three years. Vigersky and colleagues collected research from the Type 1 Diabetes Exchange …
Vintage Harve Bernard pin stripe vest dress -
9 April
Health Disparities among People with Diabetes in America and The Relationship of Race, Economic Status, and Ethnicity in Contributing to Health Inequality
Research results show that race, ethnicity, and socio-economic disparity influence the uptake of GLP-1 RA medication among people with diabetes which suggests that they are critical determinants of health. The issue of diabetes has been a topic for research over a long duration of time. Therefore, research is undertaken to …
Read More » -
9 April
DPP-4 Inhibitors Vs. Sulphonylureas As Add-On to Metformin – Assessing CV Outcomes in Type 2 Diabetes
New retrospective study results compare the two most largely prescribed antidiabetic medication classes in addition to metformin, to determine the impact on the incidence of CV events in patients with T2DM. Dipeptidyl-peptidase-4 inhibitors (DPP-4i) and sulphonylureas (sulfonylureas in the US) (SU) are two of the most prescribed medication to date …
Read More » -
9 April
Type 2 Diabetes: The Impact of Vision and Hearing Impairments on CV Risk Outcomes and Mortality
A comprehensive study reveals the importance of ophthalmologic and otologic care in patients with T2DM due to the association of increased risks for cardiovascular events in those with a decline in vision and hearing abilities. It is known that patients with type 2 diabetes mellitus (T2DM) have an increased risk …
Read More »